HLA-A, -B, -C, and -D typing was performed on 54 Norwegian patients with microscopically verified malignant melanoma. A slight, but nonsignificant, increase in the frequency of HLA-B27 and LD 108 was demonstrated among the patients, compared with healthy Norwegian controls.